Nanomedicine is on the frontline of Japan’s effort to solve an increasing cancer problem.
Focal Point |
Nanomedicine in Japan
Japan is breaking ground in areas the rest of the world will soon be addressing: old age, cancer, neuroscience. The tiny weapon of choice to defeat these diverse threats is nanomedicine. Japan has pumped millions into pursuing the dream of invisible devices, working from within to detect, diagnose and treat. It’s a strategy on the cusp of reaping significant rewards. Multidisciplinary teams are designing micelles coated in compounds to ensure their safe passage to the right areas of the body to deliver drugs where and when they are needed. The results are nothing short of remarkable.
This advertisement feature is produced by Nature Research Custom Media in partnership with The Center of Open Innovation Network for Smart Health (COINS). The advertiser retains responsibility for content. About this content.
Focal Point feature
Nanoscale doctors curing the body from within sounds like science fiction, but for Japanese research centre COINS, it’s a serious goal.
Attracting nanoparticles full of cancer drugs to the stroma of a tumour is proving key to new therapeutics.
An experimental cancer treatment combined with a high-tech operating theatre are blowing expectations away.
Japan’s Braizon Therapeutics Inc has found a cunning way to get pharmaceuticals past the blood-brain barrier by using nanotechnology to piggyback aboard glucose transporters.
Combining non-invasive imaging technologies with improved detection and analysis, will be essential if nanomedicine is to reach its true potential.